Trial Profile
Pharmacokinetics of Tamiflu (Oseltamivir) in Patients Receiving CVVHD and/or ECMO.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 20 Aug 2012 Actual end date changed from Jan 2011 to Jan 2010 as reported by ClinicalTrials.gov.
- 05 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2010 New trial record